Key Insights

Highlights

Success Rate

93% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

2.3%

1 terminated out of 43 trials

Success Rate

93.3%

+6.8% vs benchmark

Late-Stage Pipeline

9%

4 trials in Phase 3/4

Results Transparency

29%

4 of 14 completed with results

Key Signals

4 with results93% success

Data Visualizations

Phase Distribution

16Total
Not Applicable (8)
P 2 (4)
P 4 (4)

Trial Status

Recruiting16
Completed14
Unknown5
Enrolling By Invitation3
Active Not Recruiting2
Not Yet Recruiting2

Trial Success Rate

93.3%

Benchmark: 86.5%

Based on 14 completed trials

Clinical Trials (43)

Showing 20 of 20 trials
NCT04614467Phase 2TerminatedPrimary

A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction

NCT05841199Recruiting

Coronary Flow During Rapid Heart Rates

NCT07093528Recruiting

A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD

NCT06332131Enrolling By InvitationPrimary

Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature

NCT05711719Phase 2Completed

Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction

NCT06991322Not ApplicableRecruitingPrimary

Self-Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD) (SERRA-I Study)

NCT05288361Active Not Recruiting

The DISCOVER INOCA Prospective Multi-center Registry

NCT06843902Phase 2Recruiting

Improving Coronary Vascular Health in Women

NCT05984537Phase 4RecruitingPrimary

A Study on the Impact of Bivalirudin Usage During PCI for High-risk Plaques on Post-PCI Coronary Microcirculation.

NCT06795035Recruiting

Assessment of Coronary Microvascular Dysfunction After STEMI Using Continuous Saline Thermodilution

NCT03876223RecruitingPrimary

Women's Ischemia Syndrome Evaluation (WISE) Pre-HFpEF

NCT06294730Completed

COronary Microcirculation and Troponin Elevation in Septic Shock

NCT05790876Not ApplicableCompleted

Super Saturated Oxygen (SSO2) Therapy in Patients With ST-segment Elevation Myocardial Infarction (STEMI) and Action on Coronary Microcirculation Dysfunction

NCT06606821Phase 4Recruiting

The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease

NCT05272618Recruiting

Coronary Microvascular Dysfunction Assessments in Myocardial Infarction With Non-Obstructive Coronary Arteries

NCT06715137Not ApplicableCompleted

Microvascular Dysfunction in Adults with Congenital Heart Disease and the Effect of Exercise Training

NCT06597851Not ApplicableRecruitingPrimary

Insulin Resistance and Coronary Microvascular Dysfunction in Patients with Myocardial Ischemia and Non-obstructive Coronary Artery Disease

NCT04523168Not ApplicableCompletedPrimary

Feasibility and Efficacy of Coronary Sinus Narrowing in Patients With Coronary Microvascular Dysfunction

NCT06529861Not Yet RecruitingPrimary

Mechanisms Behind Microvascular Dysfunction in INOCA

NCT06503640Recruiting

Coronary Microvascular Dysfunction in Angina Patients With Non-obstructive Coronary Artery Disease (ANOCA-CMD)

Scroll to load more

Research Network

Activity Timeline